×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
21535 views

 

 

18:00
Introduction
Pr Jean-Marc Classe, Institut de Cancérologie de l’Ouest (ICO), Saint-Herblain
 
18:10
Actualités en hormonothérapie
Dr Thibault de la Motte Rouge, Centre Eugène Marquis, Rennes

18:35 Actualité en thérapies ciblées: l’évolution de la place des traitements néoadjuvants
Dr Dorothée Chocteau, Le Confluent, Institut Catherine de Sienne, Nantes
 
19:00 Actualités en radiothérapie
Dr Augustin Mervoyer, ICO, Saint-Herblain
 
19:25 Actualités en chirurgie
Dr Augustin Reynard, ICO, Angers
 
19:50 Résultats de l'étude RxPONDER chez les patientes HER2-, RH+, avec atteinte ganglionnaire
Dr Dorothée Chocteau, Le Confluent, Institut Catherine de Sienne, Nantes

 
20:10 Clôture de la soirée digitale

 

Shooting date : 2021-02-09
Last update : 2021-06-09

Suggestions

0
Days
0
Hours
0
Minutes
0
Seconds
Tuesday, December 2nd 2025 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 2nd 2025 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, December 2nd 2025 from 09am to 10:30am (GMT+1)
New York : Tuesday, December 2nd 2025 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, December 2nd 2025 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, December 2nd 2025 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, December 2nd 2025 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, December 2nd 2025 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, December 2nd 2025 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, December 3rd 2025 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, December 3rd 2025 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, December 3rd 2025 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, December 3rd 2025 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, December 3rd 2025 from 05am to 06:30am (GMT+1)

Cancers du sein : nouveautés diagnostiques

Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, October 13th 2022 from 07am to 08am (GMT+2)
San Francisco : Thursday, October 13th 2022 from 10am to 11am (GMT+2)
New York : Thursday, October 13th 2022 from 01pm to 02pm (GMT+2)
Buenos Aires : Thursday, October 13th 2022 from 02pm to 03pm (GMT+2)
Reykjavik : Thursday, October 13th 2022 from 05pm to 06pm (GMT+2)
London / Dublin : Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Paris / Berlin : Thursday, October 13th 2022 from 07pm to 08pm (GMT+2)
Istanbul : Thursday, October 13th 2022 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Thursday, October 13th 2022 from 09pm to 10pm (GMT+2)
Bangkok : Friday, October 14th 2022 from 12am to 01am (GMT+2)
Shanghai : Friday, October 14th 2022 from 01am to 02am (GMT+2)
Tokyo : Friday, October 14th 2022 from 02am to 03am (GMT+2)
Sydney : Friday, October 14th 2022 from 04am to 05am (GMT+2)
Wellington : Friday, October 14th 2022 from 06am to 07am (GMT+2)

Les inhibiteurs de tyrosine kinase (TKI) et les anticorps conjugués (ADC) dans le cancer du sein mÃ...

Les nouveaux traitements, entre choix et complémentarité

Share
Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Thursday, May 25th 2023 from 07:30am to 09am (GMT+2)
San Francisco : Thursday, May 25th 2023 from 10:30am to 12pm (GMT+2)
New York : Thursday, May 25th 2023 from 01:30pm to 03pm (GMT+2)
Buenos Aires : Thursday, May 25th 2023 from 02:30pm to 04pm (GMT+2)
Reykjavik : Thursday, May 25th 2023 from 05:30pm to 07pm (GMT+2)
London / Dublin : Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
Paris / Berlin : Thursday, May 25th 2023 from 07:30pm to 09pm (GMT+2)
Istanbul : Thursday, May 25th 2023 from 08:30pm to 10pm (GMT+2)
Moscou / Dubaï : Thursday, May 25th 2023 from 09:30pm to 11pm (GMT+2)
Bangkok : Friday, May 26th 2023 from 12:30am to 02am (GMT+2)
Shanghai : Friday, May 26th 2023 from 01:30am to 03am (GMT+2)
Tokyo : Friday, May 26th 2023 from 02:30am to 04am (GMT+2)
Sydney : Friday, May 26th 2023 from 04:30am to 06am (GMT+2)
Wellington : Friday, May 26th 2023 from 06:30am to 08am (GMT+2)

Cancer du sein RH+ : Quelles optimisations thérapeutiques en 2L métastatique ?

Share
Thursday, January 18th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Thursday, January 18th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Thursday, January 18th 2024 from 09am to 10:30am (GMT+1)
New York : Thursday, January 18th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Thursday, January 18th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Thursday, January 18th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Thursday, January 18th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Thursday, January 18th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Thursday, January 18th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Friday, January 19th 2024 from 12am to 01:30am (GMT+1)
Shanghai : Friday, January 19th 2024 from 01am to 02:30am (GMT+1)
Tokyo : Friday, January 19th 2024 from 02am to 03:30am (GMT+1)
Sydney : Friday, January 19th 2024 from 03am to 04:30am (GMT+1)
Wellington : Friday, January 19th 2024 from 05am to 06:30am (GMT+1)

Cancer du sein triple négatif métastatique

Cycle d'enseignement - Le cancer du sein

Share
Scroll Up